Immune Thrombocytopenic Purpura in a Patient With SARS-CoV-2 and Epstein-Barr Virus
Copyright © 2021, Galestanian et al..
A 35-year-old female was admitted to the hospital for menorrhagia and fatigue. Initial labs revealed that the patient had severe thrombocytopenia and also tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The main objective in this case is to describe the investigation that eventually led to a diagnosis of idiopathic thrombocytopenic purpura (ITP) in the setting of a SARS-CoV-2 coronavirus disease 2019 (COVID-19) infection and co-infection with Epstein-Barr virus (EBV). The majority of ITP cases are idiopathic and most are diagnosed and managed without hospital admission. Admission and careful management were warranted in this particular case. Interestingly, however, the patient did not have any respiratory complications associated with COVID-19. She was given 1 unit of platelets and subsequently received intravenous corticosteroids. Platelet counts improved and the patient was discharged with a course of oral prednisone. This case highlights the importance of understanding the differences between primary and secondary ITP.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Cureus - 13(2021), 2 vom: 28. Feb., Seite e13615 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Galestanian, Arbi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Revised 06.04.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.7759/cureus.13615 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM323714234 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM323714234 | ||
003 | DE-627 | ||
005 | 20231225184758.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7759/cureus.13615 |2 doi | |
028 | 5 | 2 | |a pubmed24n1079.xml |
035 | |a (DE-627)NLM323714234 | ||
035 | |a (NLM)33816014 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Galestanian, Arbi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Immune Thrombocytopenic Purpura in a Patient With SARS-CoV-2 and Epstein-Barr Virus |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 06.04.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2021, Galestanian et al. | ||
520 | |a A 35-year-old female was admitted to the hospital for menorrhagia and fatigue. Initial labs revealed that the patient had severe thrombocytopenia and also tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The main objective in this case is to describe the investigation that eventually led to a diagnosis of idiopathic thrombocytopenic purpura (ITP) in the setting of a SARS-CoV-2 coronavirus disease 2019 (COVID-19) infection and co-infection with Epstein-Barr virus (EBV). The majority of ITP cases are idiopathic and most are diagnosed and managed without hospital admission. Admission and careful management were warranted in this particular case. Interestingly, however, the patient did not have any respiratory complications associated with COVID-19. She was given 1 unit of platelets and subsequently received intravenous corticosteroids. Platelet counts improved and the patient was discharged with a course of oral prednisone. This case highlights the importance of understanding the differences between primary and secondary ITP | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a covid 19 | |
650 | 4 | |a epstein- barr virus | |
650 | 4 | |a immune thrombocytopenic purpura | |
650 | 4 | |a menorrhagia | |
650 | 4 | |a peripheral smear | |
650 | 4 | |a sars-cov-2 | |
650 | 4 | |a thrombocytopenia | |
700 | 1 | |a Suthar, Krishna H |e verfasserin |4 aut | |
700 | 1 | |a Karnath, Bernard |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cureus |d 2013 |g 13(2021), 2 vom: 28. Feb., Seite e13615 |w (DE-627)NLM24118083X |x 2168-8184 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2021 |g number:2 |g day:28 |g month:02 |g pages:e13615 |
856 | 4 | 0 | |u http://dx.doi.org/10.7759/cureus.13615 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2021 |e 2 |b 28 |c 02 |h e13615 |